Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Prescient Therapeutics Appoints Dr. Rosalind Wilson As Chief Medical Officer

PRIVATEJul 27, 2026•14 days ago

Position

Chief Medical Officer

Company

Prescient Therapeutics Limited

Dr. Rosalind Wilson
BiotechnologyHealth CareTherapeutics

Description

Prescient Therapeutics Limited has announced the appointment of Dr. Rosalind Wilson as Chief Medical Officer, effective July 13, 2026. Dr

Company Information

Company

Prescient Therapeutics Limited

About

Prescient Therapeutics Limited is focused on developing innovative therapies for oncology. The company is advancing its drug PTX-100 through clinical trials aimed at treating Cutaneous T-Cell Lymphoma. With a commitment to enhancing its clinical capabilities, it engages key stakeholders in the industry. Prescient aims to address the need for new treatment options through its robust clinical pipeline.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Prescient Therapeutics Limited's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.